Bill Hall, 71, has been fighting for his life for 38 years. These days, he’s feeling worn out.
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130 | Psychedelic Invest
Lobe Sciences Ltd. (OTCQB: LOBEF / CSE: LOBE), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced the initiation of